![]() ObsEva ObsEva is a speciality biopharmaceutical company developing drugs for womens reproductive medicine. | ![]() Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. | ![]() Avid Bioservices Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company. | |
Founding Date | Founding Date 2012 | Founding Date 2000 | Founding Date 1981 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Plan-les-Ouates, CH HQ Boston, US Sacramento, US | Locations Heidelberg, DE HQ | Locations Tustin, US HQ |
Employees | Employees 811% decrease | Employees 76 | Employees 21114% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 52.5 m | Valuation ($) 649.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €8.3m (FY, 2023) | Revenue (est.) $139.9m (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $132.6m (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit €13m (FY, 2023) | Gross profit $7.3m (FY, 2024) |
Net income | Net income N/A | Net income (€105.9m) (FY, 2023) | Net income ($140.8m) (FY, 2024) |

Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.
View company
Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.
View company